Are leukotriene receptor antagonists preferred over inhaled corticosteroids?

Are leukotriene receptor antagonists preferred over inhaled corticosteroids?

• A. Yes
• B. No
• C. Only for children
• D. Only if corticosteroids are unavailable

Answer: (B)

Leukotriene receptor antagonists and inhaled corticosteroids serve different roles in managing respiratory conditions, particularly asthma. Inhaled corticosteroids (ICS) are the first-line therapy for asthma because they effectively reduce inflammation in the airways, leading to improved lung function and decreased frequency of asthma exacerbations. ICS are well-established in clinical guidelines and have a strong evidence base supporting their efficacy and safety. Leukotriene receptor antagonists (LTRAs), while useful in many patients, especially for those with exercise-induced bronchoconstriction or allergic rhinitis components, are generally considered a supplementary option rather than a first-line treatment. They may be used in combination with inhaled corticosteroids for certain patients, but they do not replace the need for inhaled corticosteroids, particularly in individuals with moderate to severe asthma. This distinction highlights why inhaled corticosteroids are preferred over leukotriene receptor antagonists as a primary treatment approach in asthma management.

Leukotriene receptor antagonists and inhaled corticosteroids serve different roles in managing respiratory conditions, particularly asthma. Inhaled corticosteroids (ICS) are the first-line therapy for asthma because they effectively reduce inflammation in the airways, leading to improved lung function and decreased frequency of asthma exacerbations. ICS are well-established in clinical guidelines and have a strong evidence base supporting their efficacy and safety.

Leukotriene receptor antagonists (LTRAs), while useful in many patients, especially for those with exercise-induced bronchoconstriction or allergic rhinitis components, are generally considered a supplementary option rather than a first-line treatment. They may be used in combination with inhaled corticosteroids for certain patients, but they do not replace the need for inhaled corticosteroids, particularly in individuals with moderate to severe asthma.

This distinction highlights why inhaled corticosteroids are preferred over leukotriene receptor antagonists as a primary treatment approach in asthma management.